source
- UK regulator suspends new patients from receiving Tavneos (Avacopan Vifor) amid data concernsThe UK Medicines and Healthcare products Regulatory Agency (MHRA) has decided to stop prescribing Tavneos, known locally as Avacopan Vifor, to any new patients. The decision follows the regulator’…
- H1 partners with Novo Nordisk to build AI-driven data foundation for clinical developmentClinical trials are becoming more complex and data‑heavy, but decision‑making processes have not kept pace. H1 and Novo Nordisk are collaborating to address this gap. Novo Nordisk’s StudyHub links…